CCCC C4 Therapeutics, Inc.
$3.21▲ +7.72%
Healthcare
Other
After hours
$3.12▼ -2.79%
Oct 27, 4:36 PM ET
Volume 4.12M
Avg Volume (10D) 3.11M
Key Metrics & Fundamentals
Market Cap
$394.91M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.69 - 5.17
% vs 50 MA
-4.75%
% vs 200 MA
0.60%
RSI-14
53.4
MACD Histogram
+0.0600
Beta (1Y vs SPY)
1.88
Free Cash Flow
-$1.61M
Gross Rev
$6.64M
Gross Profit
$6.64M
EBITDA
-$26.13M
COGS
–
Operating Exp
$33.06M
Operating Income
-$26.42M
EBIT
-$26.42M
Pretax Income
-$23.64M
Net Income
-$23.64M
EPS (Diluted)
-0.18
Price & Volume History
Loading chart…
Recent News
Could You Have Seen The Run In Kymera Stock Coming?
Trefis · Oct 26, 2026 5:34 PM ET
Insmed Appoints Two New Directors to Its Board
PR Newswire · Oct 20, 2026 7:00 AM ET
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
Zacks · Oct 9, 2026 8:40 AM ET
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting
GlobeNewswire · Sep 25, 2026 7:00 AM ET
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
Zacks · Sep 23, 2026 9:40 AM ET
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting
GlobeNewswire · Sep 3, 2026 7:00 AM ET
Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice
Zacks · Aug 21, 2026 12:00 PM ET
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 11, 2026 8:15 AM ET
C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 11, 2026 7:00 AM ET
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 10, 2026 4:01 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CCCC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.